bpc-157 clinical trial human 2024 2025 If worked as well as the internet says it does… …we'd probably have high quality trials by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of BPC-157: What the Science Says

What It Is: A longevity peptide that targets mitochondrial function the batteries of your cells

In this model, tumors develop sequentially in mice carrying the transgene, initiating as non-angiogenic clusters of dysplastic cells, of which a proportion later develop to small angiogenic tumor islets that can progress to large vascularized tumors that metastasize to the lung

Similarly, those taking hormonal contraceptives or hormone replacement therapy may experience altered medication response due to synthetic hormone interactions

Keeping regular appointments can keep you healthy and energized

This ban lifting is baseless and will give the public a sense of legitimacy for a peptide with no clinical trial data to support safety or efficacy The pro-peptide stacked FDA advisory committee voted to lift the ban for BPC-157, as expected